This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Dow Drops Amid Soft Underlying Durable Goods

NEW YORK (TheStreet) -- Markets dropped Wednesday as the latest headlines on durable goods orders ultimately failed to generate enthusiasm about U.S. manufacturing conditions.

Still, health care stocks were a bright spot, rising after biotechs were hard-hit earlier this week.

  • The Dow Jones Industrial Average lost 0.6% to 16,268.99, while the S&P 500 dropped 0.7% to 1,852.56. The Nasdaq fell 1.43% to 4,173.58.
  • U.S. durable goods orders increased by a more-than-expected 2.2% in February. Economists were expecting a 1% rebound. Still, the report came with soft underlying data.
  • "The headline increase in durable orders in February reflects a strong rebound in transportation orders after significant weakness at the end of 2013 and the start of 2014," Sterne Agee chief economist Lindsey Piegza said in a note. "However, transportation aside, demand remains tepid with businesses still clearly sidelined in terms of investment."
  • The March Markit PMI Services Flash showed U.S. private sector economic activity accelerating at a faster rate then February, with the index hitting 55.8 from 54.1 a month earlier.
  • International markets were broadly higher as stimulus chatter flowed out of Europe and China, with the DAX in Germany finishing ahead by 1.18% and the FTSE 100 up 0.01% after trading well into positive territory for most of the day. The Hong Kong Hang Seng settled up 0.72%, and the Nikkei 225 in Japan closed up 0.37%.
  • European Central Bank governing council member and Bundesbank head, Jens Weidmann, said Wednesday that negative interest rates are being considered to help cool down the euro and that quantitative easing proposals were also being discussed amid the fight against deflationary pressures. China stimulus talk was heating up after the approval of five railway projects by China's main economic planning agency.
  • Top gainers in the S&P included Tenet Healthcare (THC - Get Report), Quest Diagnostics (DGX) (up more than 5%) and PVH (PVH), which gained 3.5%. PVH announced earnings of $1.43 a share in the fourth quarter, higher than earlier projections of $1.40. The health care theme was also prevalent in the Dow, with Merck (MRK - Get Report), Pfizer (PFE) and UnitedHealth Group (UNH) the top gainers.
  • Toyota (TM) advanced 1.9% as it gets ready to repurchase up to 1.89% of its shares, worth as much as $3.5 billion.
  • King Digital (KING) saw shares slide 15.6% to $19 on their first day of trading on the New York Stock Exchange after pricing its IPO of 22.2 million shares at $22.50 a share. It raised close to $500 million.
  • Facebook (FB - Get Report) shed 6.6% after buying headset maker Oculus VR for $2 billion.
  • President Obama's speech in Brussels was followed by a reassertion by the U.S. president and EU leaders that they continue to cooperate to isolate Russia with the threat of economic sanctions, especially from the energy route. The president also discussed Wednesday with European and North Atlantic Treaty Organization leaders about strengthening their military presence in Eastern and Central European regions situated near Russia amid its annexation of Crimea.

-- By Jane Searle, Andrea Tse and Joe Deaux in New York

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
FB $78.97 0.00%
KING $15.79 0.00%
MRK $58.54 0.00%
THC $46.30 0.00%
AAPL $128.46 0.00%

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs